Evidence map›Paper›PMID 26635035›Full record

ArticleHaematologica2016

von Willebrand factor binds to the surface of dendritic cells and modulates peptide presentation of factor VIII.

Nicoletta Sorvillo, Robin B Hartholt, Esther Bloem, Magdalena Sedek, Anja ten Brinke, Carmen van der Zwaan, Floris P van Alphen, Alexander B Meijer, Jan Voorberg

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Development of inhibitors in hemophilia A: An illustrated review.Research and practice in thrombosis and haemostasis · 2020
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Tolerating Factor VIII: Recent Progress.Frontiers in immunology · 2019
    Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Nicoletta SorvilloDepartment of Plasma Proteins, Sanquin-AMC Landsteiner Laboratory, Amsterdam, the Netherlands Current address: Harvard Medical School Program in Cellular and Molecular Medicine, Boston Children's Hospital, USA.
Robin B HartholtDepartment of Plasma Proteins, Sanquin-AMC Landsteiner Laboratory, Amsterdam, the Netherlands.
Esther BloemDepartment of Plasma Proteins, Sanquin-AMC Landsteiner Laboratory, Amsterdam, the Netherlands.
Magdalena SedekDepartment of Plasma Proteins, Sanquin-AMC Landsteiner Laboratory, Amsterdam, the Netherlands.
Anja ten BrinkeDepartment of Immune Pathology, Sanquin-AMC Landsteiner Laboratory, Amsterdam, the Netherlands.
Carmen van der ZwaanDepartment of Plasma Proteins, Sanquin-AMC Landsteiner Laboratory, Amsterdam, the Netherlands.
Floris P van AlphenDepartment of Plasma Proteins, Sanquin-AMC Landsteiner Laboratory, Amsterdam, the Netherlands.
Alexander B MeijerDepartment of Plasma Proteins, Sanquin Blood Supply Foundation, Amsterdam and the Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands.
Jan VoorbergDepartment of Plasma Proteins, Sanquin-AMC Landsteiner Laboratory, Amsterdam, the Netherlands j.voorberg@sanquin.nl.
Sanquin · NLHarvard University · USUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been proposed that von Willebrand factor might affect factor VIII immunogenicity by reducing factor VIII uptake by antigen presenting cells. Here we investigate the interaction of recombinant von Willebrand factor with immature monocyte-derived dendritic cells using flow cytometry and confocal microscopy. Surprisingly, von Willebrand factor was not internalized by immature dendritic cells, but remained bound to the cell surface. As von Willebrand factor reduces the uptake of factor VIII, we investigated the repertoire of factor VIII presented peptides when in complex with von Willebrand factor. Interestingly, factor VIII-derived peptides were still abundantly presented on major histocompatibility complex class II molecules, even though a reduction of factor VIII uptake by immature dendritic cells was observed. Inspection of peptide profiles from 5 different donors showed that different core factor VIII peptide sequences were presented upon incubation with factor VIII/von Willebrand factor complex when compared to factor VIII alone. No von Willebrand factor peptides were detected when immature dendritic cells were pulsed with different concentrations of von Willebrand factor, confirming lack of von Willebrand factor endocytosis. Several von Willebrand factor derived peptides were recovered when cells were pulsed with von Willebrand factor/factor VIII complex, suggesting that factor VIII promotes endocytosis of small amounts of von Willebrand factor by immature dendritic cells. Taken together, our results establish that von Willebrand factor is poorly internalized by immature dendritic cells. We also show that von Willebrand factor modulates the internalization and presentation of factor VIII-derived peptides on major histocompatibility complex class II.

Indexed as

Amino Acid SequenceAntigen PresentationBinding SitesCell DifferentiationDendritic CellsEndocytosisFactor VIIIHLA-DRB1 ChainsHumansMonocytesPeptidesPrimary Cell CultureProtein BindingRecombinant Proteinsvon Willebrand FactorFactor VIIIHLA-DRB1 ChainsPeptidesRecombinant Proteinsvon Willebrand Factor

Identifiers

PMID26635035
PMCPMC4815722
OpenAlexW2196289212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.